Generic complex injectable pharmaceutical manufacturer with 5 drugs pending approval and proven track record.
The two main partners sold their stake in a previous company almost 10 years back and have now created their own new company.
They hold over 40 patents and are on the verge of their first approved generic complex injectable drug in a couple of months.
The facility was inspected very recently by the FDA and passed.
We have 5 drugs pending approval with a total market value of over USD 4B and only a few competitors.
The company should be worth USD 2B in another 3 years.
The business has not generated any revenue because we have been in the process of R&D in developing these drugs for the past 6 years and have invested over USD 40 million in the business.
0
0
0
0
0